ReviewJournal of nephrology2025
Longitudinal studies: focus on trajectory analysis in kidney diseases.
Review in Journal of nephrology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Trajectory analysis in clinical research.Clinical kidney journal · 2026Review
- Identifying Distinct Trajectories and Predictors of Professional Identity in Nursing Interns: A Prospective Cohort Study.Nursing open · 2026Article
- Development and validation of a nomogram for predicting heterogeneous patient-reported outcome recovery trajectories after lung cancer surgery: a retrospective study.Journal of cardiothoracic surgery · 2026Article
- Association between serum anion gap trajectory and mortality in hospitalized patients with sepsis: an analysis of the MIMIC-IV database.Frontiers in endocrinology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Longitudinal cohort studies are pivotal in medical research for understanding disease progression over time. These studies track a group of individuals across multiple time points, enabling the identification of risk factors and the evaluation of interventions. Traditional methods like linear mixed models, generalized estimating equations, and survival analysis often fall short in capturing the complex, non-linear patterns of disease progression. Trajectory analysis, a statistical technique that identifies distinct paths within longitudinal data, offers a more nuanced approach. This review delves into the methodological foundations of trajectory analysis, including data preparation, model selection, parameter estimation, model evaluation, and interpretation. It highlights the advantages of trajectory analysis, such as its ability to capture heterogeneity, handle various data types, and enhance predictive power. The application of trajectory analysis in nephrology, particularly in chronic kidney disease and diabetic nephropathy, demonstrates its utility in identifying distinct subgroups with different disease trajectories. Studies have shown that trajectory analysis can uncover patterns of renal function decline and proteinuria progression, providing insights that inform personalized treatment strategies. Despite its strengths, trajectory analysis requires advanced statistical knowledge, computational resources, and large sample sizes, which can be barriers for some researchers. Nevertheless, its ability to reveal complex disease patterns and improve predictive accuracy makes it a valuable tool in longitudinal studies. This review underscores the potential of trajectory analysis to enhance our understanding of disease progression and improve patient outcomes in nephrology and beyond.
Indexed as
Identifiers
39644432What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.